| Authors: |
Sim GC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. laszlo.radvanyi@emdserono.com gcsim1@yahoo.co.uk.; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Liu C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang E; Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar., Liu H; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland., Creasy C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Dai Z; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Overwijk WW; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Roszik J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Marincola F; Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Grimm E; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Radvanyi L; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. laszlo.radvanyi@emdserono.com gcsim1@yahoo.co.uk.; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. |
